The 88 references in paper L. Rakhmatullina N., K. Gurevich Y., Л. Рахматуллина Н., К. Гуревич Я. (2013) “ПРИМЕНЕНИЕ БИОИМПЕДАНСНОГО МОНИТОРА СОСТАВА ТЕЛА (ВСМ) В КЛИНИЧЕСКОЙ ПРАКТИКЕ У ДИАЛИЗНЫХ БОЛЬНЫХ (ОБЗОР ЛИТЕРАТУРЫ) // APPLICATION BIOIMPEDANCE BODY COMPOSITION МОNITOR (BCM) IN CLINICAL PRACTICE IN DIALYSIS PATIENTS (LITERATURE REVIEW)” / spz:neicon:nefr:y:2013:i:4:p:49-57

1
Шишкин АН, Федорова ЮЮ. Интрадиализная гипотония: факторы, ассоциированные с процедурой гемодиализа. Нефрология 2012; 16 (2): 64-68
(check this in PDF content)
2
Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001; 38 [Suppl 4]: 11-17
(check this in PDF content)
3
Ozkahya M, Toz H, Qzerkan E et al. Impact of blood control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002; 15: 655-660
(check this in PDF content)
4
Cocchi R, Degli EE, Fabbri A et al. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant 1999; 14: 1536–1540
(check this in PDF content)
5
Woodrow G, Devine Y, Cullen M, Lindley E. Application of bioelectrical impedance to clinical assessment of body composition in peritoneal dialysis. Perit Dial Int 2007; 27: 496 -502
(check this in PDF content)
6
Agarwal R, Andersen MJ, Pratt JH. On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 153–158
(check this in PDF content)
7
Бовкун ИВ, Румянцев АШ. Оценка тактики проведения сеанса гемодиализа у больных с разной величиной артериального давления. Нефрология 2006; 10 (3): 62-67
(check this in PDF content)
8
Новикова НА, Гендлин ГЕ, Сторожаков ГИ и др. Выживаемость больных хронической терминальной почечной недостаточностью, получающих постоянный амбулаторный перитонеальный диализ. Клиническая нефрология 2010; 4: 26-33
(check this in PDF content)
9
Machek P, Jirka T, Moissl U et al. Optimal fluid status assessed with bioimpedance spectroscopy reduces IMES and hospitalisation in hemodialysis patients. Nephrol Dial Transplant plus 2008; 1(Suppl 2): 322
(check this in PDF content)
10
Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1574–1579
(check this in PDF content)
11
Ляшенко ОА, Корнеев АМ, Гуревич КЯ. Коррекция артериальной гипертензии у больных на программном гемодиализе. Врач 2011; 2: 63-66
(check this in PDF content)
12
Ates K, Nergizoglu G, Keven K et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60: 767–776
(check this in PDF content)
13
Brown EA, Davies SJ, Rutherford P et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: 2948-2957.
(check this in PDF content)
14
Menon MK, Naimark DM, Bargman JM et al. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 2001; 16 (11): 2207–2213.
(check this in PDF content)
15
Tonbul Z, Altintepe L, Sözlü C et al. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int 2003; 23 (1): 46–52
(check this in PDF content)
16
Wong PN, Mak SK, Lo KY et al. Factors associated with poorly-controlled hypertension in continuous ambulatory peritoneal dialysis patients. Singapore Med J 2004; 45 (11): 520–524
(check this in PDF content)
17
Konings CJAM., Kooman JP, Schonck M et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22: 477 – 487
(check this in PDF content)
18
Дудко МЮ, Шутов ЕВ, Капитанов ЕН, Ермоленко ВМ. Влияние нарушений водного баланса на состояние сердечнососудистой системы у больных на заместительной почечной терапии. Нефрология и диализ 2006; 8 (3): 244-249
(check this in PDF content)
19
Ляшенко ОА, Гуревич КЯ, Корнеев АМ. Клинические, лабораторные и инструментальные характеристики, ассоциированные с артериальной гипертензией у больных, находящихся на программном гемодиализе. Нефрология
(check this in PDF content)
20
1; 15 (2): 49-56 20. Ветчинникова ОН, Пронина ВП, Агальцов МВ, Кантария РО. Ремоделирование левого желудочка сердца у больных на перитонеальном диализе. Клиническая нефрология 2012; 1: 21-30
(check this in PDF content)
21
Sinha AD, Agarwal R. Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status. Semin Dial 2009; 22: 480–482
(check this in PDF content)
22
Agarwal R, Alborzi P, Satyan S et al. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009; 53: 500–507
(check this in PDF content)
23
Kayikcioglu M, Tumuklu M, Ozkahya M et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 2009; 24: 956–962
(check this in PDF content)
24
Wang X, Axelsson J, Lindholm B, Wang T. Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients. Blood Purif 2005; 23: 373–378
(check this in PDF content)
25
Kutlay S, Dincer I, Sengul S et al. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients. Am J Kidney Dis 2006; 47: 485–492
(check this in PDF content)
26
Белов ВВ, Ильичева ОЕ. Динамика показателей хронической сердечной недостаточности у больных хронической болезнью почек при почечно-заместительной терапии. Нефрология 2006; 10 (1): 35-39
(check this in PDF content)
27
Charra B, Chazot C. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron Physiol 2003; 93: 94–101
(check this in PDF content)
28
D’Amico G, Locatelli F. Hypertension in dialysis: pathophysiology and treatment. J Nephrol 2002; 15: 438–445
(check this in PDF content)
29
Levin NW. What clinical insights from the early days of dialysis are being overlooked today? Semin Dial 2005; 18: 13–14
(check this in PDF content)
30
Saint-Remy A, Krzesinski JM. Optimal blood pressure level and best measurement procedure in hemodialysis patients. Vasc Health Risk Manag 2005; 1: 235–244
(check this in PDF content)
31
Li Z, Lacson E, Lowrie EG, Ofsthun N et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 2006; 48: 606–615
(check this in PDF content)
32
Шутов АМ, Мастыков ВЭ, Едигарова ОМ. Использование допплер-эхокардиографии для уточнения «сухого веса» больного на программном гемодиализе. Нефрология 2004; 8(2): 35-39
(check this in PDF content)
33
Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004; 66(3):1212-1220
(check this in PDF content)
34
Stegmayr BG. Ultrafiltration and Dry Weight – What are the Cardiovascular Effects? Artif Organs 2003; 27(3): 227 – 229
(check this in PDF content)
35
Zucchelli P, Santoro A. Dry weight in hemodialysis: volemic control. Semin Nephrol 2001; 3: 286-290
(check this in PDF content)
36
Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized controlled trial. J Am Soc Nephrol 2002; 13:1307–1320
(check this in PDF content)
37
Davies SJ, Woodrow G, Donovan K et al. Icodextrin improves fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338–2344
(check this in PDF content)
38
Asci G, Ozkahya M, Duman S et al. Volume control associated with better cardiac function in longterm peritoneal dialysis patients. Perit Dial Int 2006; 26:85–88
(check this in PDF content)
39
Wong PN, Mak SK, Lo KY, Tong GM, Wong AK. Factors associated with poorly-controlled hypertension in continuous ambulatory peritoneal dialysis patients. Singapore Med J 2004; 45 (11): 520–524
(check this in PDF content)
40
Nishimura K, Kamiya Y, Miyamoto K et al. Molecular weight of polydisperse icodextrin effects its oncotic contribution to water transport. J Artif Organs 2008; 11;165-169
(check this in PDF content)
41
Lin X, Lin A, Ni Z et al. Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients. Nephrol Dial Transplant 2010; 25:2322-2327
(check this in PDF content)
42
Jansen MA, Termorshuizen F, Korevaar JC et al. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 2005; 68:1199-1205
(check this in PDF content)
43
Biesen W, Verbeke F, Devolder I, Vanholder R. The relation between salt, volume, and hypertension: clinical evidence for forgotten but still valid basic physiology. Perit Dial Int 2008; 28: 596–600
(check this in PDF content)
44
Biesen W, Williams JD, Covic AC et al. Fluid Status in Peritoneal Dialysis Patients: The European Body Composition Monitoring (EuroBCM) Study Cohort. PLoS ONE 2011; 6(2): e17148
(check this in PDF content)
45
Davison SN, Jhangri GS, Jindal K, Pannu N. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis. Clin J Am Soc Nephrol 2009; 4: 1044–1050
(check this in PDF content)
46
Huang WH, Chen KH, Hsu CW et al. Residual renal function – one of the factors associated with arterial stiffness in peritoneal dialysis patients: Insight from a retrospective study in 146 peritoneal dialysis patients. Blood Purif 2008; 26: 133-137
(check this in PDF content)
47
Wang AY. The John F. Maher Award Recipient Lecture 2006. The “heart” of peritoneal dialysis: residual renal function. Perit Dial Int 2007; 27: 116-124
(check this in PDF content)
48
Han SH, Lee SC, Ahn SV et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 2007; 22: 2653-2658
(check this in PDF content)
49
Chandna SM, Kulinskaya E, Farrington K. A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency. Nephrol Dial Transplant 2005; 20: 2130-2138
(check this in PDF content)
50
Biesen W, Vanholder R, Veys N, Lameire N. Peritoneal dialysis in anuric patients: concerns and cautions. Semin Dial 2002; 15: 305-310
(check this in PDF content)
51
Jansen MAM, Hart AAM, Korevaar JC et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046–1053
(check this in PDF content)
52
Davies SJ, Brown EA, Reigel W et al. What is the link between poor ultrafiltration and increased mortality in anuric patients on automated peritoneal dialysis? Analysis of data from EAPOS. Perit Dial Int 2006; 26: 458–465
(check this in PDF content)
53
Wiggins KJ, Rumpsfeld M, Hawley CM, O’Shea A et al. Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion. Nephrology (Carlton) 2007; 12: 218–223
(check this in PDF content)
54
Sipahioglu MH, Aybal A, Unal A et al. Patient and technique survival and factors affecting mortality on peritoneal dialysis in Turkey: 12 years’ experience in a single center. Perit Dial Int 2008; 28(3): 238–245
(check this in PDF content)
55
Carmona RA, Fontan PM, Naveiro GR et al. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 2004; 44:132-145
(check this in PDF content)
56
Davenport A, Willicombe M. Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi – frequency bioimpedance. Int J Artif Organs 2009; 32:779-786
(check this in PDF content)
57
Pierratos A. Daily nocturnal home hemodialysis. Kidney Int 2004; 65:1975–1986
(check this in PDF content)
58
Wabel P, Moissl U, Chamney P et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23:2965–2971
(check this in PDF content)
59
Ozkahya M, Ok E, Toz H et al. Long-termsurvival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 2006; 21: 3506–3513
(check this in PDF content)
60
Fagugli RM, Pasini P, Quintaliani G et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysispatients. Nephrol Dial Transplant 2003;18: 2332–2338
(check this in PDF content)
61
Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA 2007; 298 (11): 1291–1299
(check this in PDF content)
62
Davies S, Carlsson O, Simonsen O et al. The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant 2009; 24: 1609–1617
(check this in PDF content)
63
Paula FM, Peixoto AJ, Pinto LV et al. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int 2004; 66 [Suppl 3]: 1232–1238
(check this in PDF content)
64
Kalantar-Zadeh K, Regidor DL, Kovesdy CP et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 2009;119: 671-679
(check this in PDF content)
65
Родин И.Н. Инструментальное определение «сухого веса» и оптимального объема ультрафильтрации у больных в условиях лечения программным гемодиализом. Нефрология и диализ 2002; 4(1): 41-44
(check this in PDF content)
66
Zhu F, Wystrychowski G, Kitzler T et al. Application of bioimpedance techniques to peritoneal dialysis. Contrib Nephrol 2006; 150: 119–128
(check this in PDF content)
67
Devolder I, Verleysen A, Vijt D et al. Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int 2010; 30:1-7
(check this in PDF content)
68
Мартиросов ЭГ, Николаев ДВ, Руднев СГ. Технологии и методы определения состава тела человека. Наука, М., 2006; 102-127
(check this in PDF content)
69
Николаев ДВ, Смирнов АВ, Бобринская ИГ, Руднев СГ. Глава 2. Биоимпеданс и его измерение. В: Биоимпедансный анализ состава тела человека. Наука, М., 2009; 49-89
(check this in PDF content)
70
Moissl UM, Wabel P, Chamney PW et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas 2006; 27: 921–933
(check this in PDF content)
71
Chamney PW, Wabel P, Moissl UM et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 2007; 85: 80–89
(check this in PDF content)
72
Moissl U, Bosaeus I, Lemmey A et al. Validation of a 3C model for determination of body fat mass. J Am Soc Nephrol 2007; 18 A: 257
(check this in PDF content)
73
Moissl U, Wabel P, Chamney PW et al. Validation of a bioimpedance spectroscopy method for the assessment of fat free mass. NDT Plus 2008; 1(Suppl 2): 215
(check this in PDF content)
74
Wabel P, Chamney PW, Moissl U et al. Reproducibility of bioimpedance spectroscopy (BIS) in health and disease (abstract). Nephrol Dial Transplant 2007; 22 [Suppl 6]: 137
(check this in PDF content)
75
Wabel P, Chamney P, Moissl U, Jirka T. Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif 2009; 27: 75-80
(check this in PDF content)
76
Passauer J, Miller H, Schleser A et al. Evaluation of clinical dry weight assessment in haemodialysis patients by bioimpedance spectroscopy. J Am Soc Nephrol 2007; 18 A: 256
(check this in PDF content)
77
Wizemann V, Rode C, Wabel P. Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. Contrib Nephrol 2008; 161: 115–118
(check this in PDF content)
78
Wabel P, Moissl U, Chamney P et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23: 2965–2971
(check this in PDF content)
79
Passauer J, Petrov H, Schleser A. Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: a cross-sectional study. Nephrol Dial Transplant 2009; 1: 1–7
(check this in PDF content)
80
Ponce P, Taborsky P, Vlasak J. Assessment and reduction of fluid overload using a body composition monitor. NDT Plus 2009; 2 (4): 335-336
(check this in PDF content)
81
Onofriescu M, Mardare NG, Segall L et al. Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol 2012; 44(2): 583-591
(check this in PDF content)
82
Tapolyai M, Faludi M, Reti V et al. Dialysis patients fluid overload, antihypertensive medications, and obesity. J ASAIO 2011; 57(6): 511-515
(check this in PDF content)
83
Machek P, Jirka T, Moissl U et al. Guided optimization of fluid status in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 538–544
(check this in PDF content)
84
Parmentier SP, Schirutschke H, Schmitt B et al. Influence of peritoneal dialysis solution on measurements of fluid status by bioimpedance spectroscopy (abstract). Int Urol Nephrol 2012; http:// www.springerlink.com/content/2v08u83q00u62t18/
(check this in PDF content)
85
Rosina J, Vranova J, Remes O et al. Bioimpedance Spectroscopy as a noninvasive method of determination of the hydration status in hemodialysis patients. Acta Mechanica Slovaca 2010; 14 (2): 72-77
(check this in PDF content)
86
Cheriex E, Leunissen K, Janssen J et al. Echography of the inferior vena cava is a simple and reliable tool for estimation of «dry weight» in hemodialysis patients. Nephrol Dial Transplant 1989; 4: 563–568
(check this in PDF content)
87
Hur E, Gungor O, Musayev O et al. Bioimpedance spectroscopy for the detection of hypervolemia in peritoneal dialysis patients. Adv Perit Dial 2011; 27: 65-70
(check this in PDF content)
88
Sipahi S, Hur E, Demirtas S et al. Body composition monitor measurement technique for the detection of volume status in peritoneal dialysis patients: the effect of abdominal fullness. Int Urol Nephrol 2011; 43(4):1195-1199 Поступила в редакцию 17.05.2013 г.
(check this in PDF content)